Five Year Summary
SEK million 2017 2016 2015 2014 2013
Net sales 329,2 311.6 283.2 187.7 175.5
Gross profit 146,6 158.7 132.5 70.4 57.4
Gross margin 44,5% 50.9% 46.8% 37.5% 32.7%
EBITDA 3,1 29.1 12.8 -34.1 -31.4
Result after financial items -39,9 -1.3 -19.9 -61.4 -57.6
Earnings per share, SEK -0,52 -0.04 -0.27 -0.82 -0.9
Equity per share, SEK 0,52 -0.95 0.98 1.23 1.55

Development

Product Development

Contact us

Bluefish Pharmaceuticals AB
Gävlegatan 22
SE-113 30 Stockholm
Sweden
Tel: +46 8 5191 1600
Fax: +46 8 5191 1690
info-se@bluefishpharma.com